Artificial placentas, pregnancy loss and loss-sensitive care
Elizabeth Chloe Romanis1, Victoria Adkins2,3
1Centre for Ethics and Law in the Life Sciences, Durham Law School, Durham University, Durham, UK elizabeth.c.romanis@durham.ac.uk.
Journal of Medical Ethics
|November 6, 2023
Summary
Artificial placenta technology may highlight pregnancy loss separate from procreative loss. This technology necessitates new considerations for patient care and counseling, focusing on the embodied experience of pregnancy.
Area of Science:
- Bioethics
- Reproductive Medicine
- Philosophy of Medicine
Background:
- Pregnancy loss is often conflated with procreative loss, where the fetus dies.
- Existing recognition of pregnancy loss occurs when neonates require intensive care after premature birth.
Purpose of the Study:
- To explore pregnancy loss as distinct from procreative loss, particularly in the context of emerging artificial placenta technology.
- To analyze the potential impact of artificial placentas on the experience and visibility of pregnancy loss.
- To propose practical recommendations for care pathways and language surrounding artificial placenta use.
Main Methods:
- Philosophical analysis of pregnancy, gestation, and loss.
- Examination of existing experiences of pregnancy loss in neonatal intensive care settings.
- Consideration of future implications of artificial placenta technology.
Main Results:
- Pregnancy loss can occur independently of procreative loss, even when the gestated entity survives.
- Artificial placenta technology may intensify and make more visible the experience of pregnancy loss without procreative loss.
- The embodied nature of pregnancy and the separability of gestation from pregnancy are key concepts.
Conclusions:
- Pregnancy is an embodied state, but gestation is a process that can be separated from the experience of pregnancy.
- Artificial placentas necessitate a re-evaluation of pregnancy loss, emphasizing non-fetal-centric perspectives.
- Recommendations include specialized counseling and careful language use in clinical settings involving artificial placentas.


